# Valence Life Sciences

Valence Life Sciences is a Private Equity based in New York, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** New York, United States
- **Region:** North America
- **Address:** New York, NY, United States
- **Founded:** 2012
- **Assets under management:** Undisclosed
- **Website:** www.valencefund.com
- **LinkedIn:** https://www.linkedin.com/company/valence-life-sciences-gp-ii-llc

## Regulatory record

- **Reports private funds:** No

## About

Valence Life Sciences is a life sciences investment firm focused on late-stage private and micro-cap public drug development companies. The firm manages the Valence Advantage Life Sciences Fund II, which invests in late-stage companies through a targeted strategy. Established in 2012 as a successor to Caxton Advantage Life Sciences Fund I, Valence Advantage Life Sciences is an independent entity.

## Sectors

- Digital Health
- Healthcare Services
- AI/ML

## Questions

### What does Valence Life Sciences invest in?

Valence targets life sciences companies that use computation and artificial intelligence as core components of their therapeutic or diagnostic platforms. The firm invests across venture and growth stages, focusing on drug discovery platforms, digital health infrastructure, and precision medicine rather than traditional asset-centric biotech plays.

## Related profiles

- [Valence8](https://altss.com/profile/valence8)
- [Valencia Capital](https://altss.com/profile/valencia-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/valence-life-sciences

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology